Mars Finance News, on March 21, YZi Labs announced that Jane He has been appointed as a general partner, and will lead its biotechnology investments, while also contributing to YZi Labs' broader AI and Web3 strategy. YZi Labs stated that after graduating from Stanford University GSB, Jane has a strong track record in biotechnology and medical technology, actively seeking disruptive opportunities at the intersection of artificial intelligence and biotechnology. Her expertise covers cancer treatment, gene editing, metabolic therapy, and AI-driven biotechnology solutions, bringing a visionary approach to investments. Biotechnology is at the forefront of scientific innovation and will transform broader human experiences - from life-saving therapies to AI-driven medical breakthroughs. Jane's appointment reflects YZi Labs' firm commitment to supporting this transformative industry and driving it forward.